Jenna McCarthy joined the corporate department in 2019 and practices primarily with the life sciences regulatory and compliance and health care groups. During law school, Jenna served as the notes development editor for the Vanderbilt Journal of Transnational Law, and was an active member of the Vanderbilt Moot Court Board. She also served as the president of the Vanderbilt Women Law Students Association. During the summer of 2017, Jenna interned with the U.S. Securities and Exchange Commission.
Before law school, she taught English in Chiang Mai, Thailand through a Princeton-in-Asia fellowship, and worked as a paralegal at Ropes & Gray.
- Performed FDA regulatory diligence for corporate transactions involving pharmaceutical, medical device, food, and cosmetics companies.
- Assisted a pharmaceutical company with an internal investigation related to compliance, data integrity, Good Manufacturing Practices, and other quality concerns.
- Assisted a pharmaceutical company with the patent listing process and provided advice regarding patent exclusivity, patent term extension, and patent listing dispute issues.
- Advised private equity clients regarding implications of the CARES Act to FDA-regulated life sciences portfolio companies.
- Advised pro bono client regarding latest FDA guidance and emergency use authorizations for COVID-19 personal protective equipment and in vitro diagnostic tests.
- Co-author, “Incentives And Risks From OTC Drug Monograph Revamp” Law360 (May 29, 2020)
- JD, Vanderbilt University Law School, 2019; Notes Development Editor, Vanderbilt Journal of Transnational Law
- AB (Politics), Princeton University, 2013